Kansuinine B
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Kansuinine B
Description :
Kansuinine B inhibits IL-6-induced Stat3 activation. Kansuinine B possesses anti-viral activity and could be used in the study for COVID-19[1][2][3].UNSPSC :
12352005Target :
Interleukin Related; SARS-CoVType :
Natural ProductsRelated Pathways :
Anti-infection; Immunology/InflammationApplications :
COVID-19-anti-virusField of Research :
Infection; Inflammation/ImmunologyAssay Protocol :
https://www.medchemexpress.com/kansuinine-b.htmlPurity :
99.0Solubility :
DMSO : 25 mg/mL (ultrasonic)Smiles :
O=C(C1(C)C)[C@H](O)[C@@H](OC(C2=CC=CC=C2)=O)C([C@H](OC(C3=CC=CC=C3)=O)[C@]([C@@H](OC(C)=O)[C@](C)(O)[C@@H]4O)([H])[C@@]4(OC(C)=O)C([C@@H](C)[C@@]5([H])[C@@]1([H])O5)=O)=CMolecular Formula :
C38H42O14Molecular Weight :
722.73References & Citations :
[1]Jong Sun Chang, et al. Kansuinine A and Kansuinine B from Euphorbia kansui L. inhibit IL-6-induced Stat3 activation. Planta Med. 2010 Oct;76 (14) :1544-9.|[2]Xiaoyun Shu, et al. Bioassay-guided separation of the proinflammatory constituents from the roots of Euphorbia kansui. J Nat Med. 2010 Jan;64 (1) :98-103.|[3]YASER DAANIAL , et al. PROMISING COMPOUNDS FOR TREATMENT OF COVID-19. VAWKUM Transactions on Computer Sciences, ISSN (e) :2308-8168, ISSN (p) : 2411-6335. Volume 17, Number 1, January-June, 2020.Shipping Conditions :
Room TemperatureStorage Conditions :
4°C (Powder, sealed storage, away from moisture)Scientific Category :
Natural ProductsClinical Information :
No Development ReportedIsoform :
IL-6CAS Number :
[57685-46-8]

